Global Drugs for Herpes Labialis (Oral Herpes) Market Insights and Forecast to 2031

Report ID: 1152866 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Aciclovir
        1.2.3 Valacyclovir
        1.2.4 Famciclovir
        1.2.5 Docosanol
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 External Use
        1.3.3 Oral
        1.3.4 Injection
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Perspective (2017-2028)
    2.2 Drugs for Herpes Labialis (Oral Herpes) Growth Trends by Region
        2.2.1 Drugs for Herpes Labialis (Oral Herpes) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Region (2017-2022)
        2.2.3 Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Region (2023-2028)
    2.3 Drugs for Herpes Labialis (Oral Herpes) Market Dynamics
        2.3.1 Drugs for Herpes Labialis (Oral Herpes) Industry Trends
        2.3.2 Drugs for Herpes Labialis (Oral Herpes) Market Drivers
        2.3.3 Drugs for Herpes Labialis (Oral Herpes) Market Challenges
        2.3.4 Drugs for Herpes Labialis (Oral Herpes) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue
        3.1.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue (2017-2022)
        3.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Players (2017-2022)
    3.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Drugs for Herpes Labialis (Oral Herpes) Revenue
    3.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio
        3.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2021
    3.5 Drugs for Herpes Labialis (Oral Herpes) Key Players Head office and Area Served
    3.6 Key Players Drugs for Herpes Labialis (Oral Herpes) Product Solution and Service
    3.7 Date of Enter into Drugs for Herpes Labialis (Oral Herpes) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Herpes Labialis (Oral Herpes) Breakdown Data by Type
    4.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Type (2017-2022)
    4.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2023-2028)
5 Drugs for Herpes Labialis (Oral Herpes) Breakdown Data by Application
    5.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Application (2017-2022)
    5.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size (2017-2028)
    6.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        6.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022)
        6.2.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028)
        6.2.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2017-2028)
    6.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        6.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022)
        6.3.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028)
        6.3.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2017-2028)
    6.4 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country
        6.4.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2017-2022)
        6.4.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size (2017-2028)
    7.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        7.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022)
        7.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028)
        7.2.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2017-2028)
    7.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        7.3.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022)
        7.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028)
        7.3.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2017-2028)
    7.4 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country
        7.4.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2017-2022)
        7.4.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size (2017-2028)
    8.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        8.2.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        8.3.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region
        8.4.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size (2017-2028)
    9.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        9.2.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022)
        9.2.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028)
        9.2.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2017-2028)
    9.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        9.3.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022)
        9.3.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028)
        9.3.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2017-2028)
    9.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country
        9.4.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2017-2022)
        9.4.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size (2017-2028)
    10.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
        10.2.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
        10.3.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country
        10.4.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 GSK
        11.1.1 GSK Company Details
        11.1.2 GSK Business Overview
        11.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.1.4 GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.1.5 GSK Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.2.4 Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Teva
        11.3.1 Teva Company Details
        11.3.2 Teva Business Overview
        11.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.3.4 Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.3.5 Teva Recent Developments
    11.4 Mylan
        11.4.1 Mylan Company Details
        11.4.2 Mylan Business Overview
        11.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.4.4 Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.4.5 Mylan Recent Developments
    11.5 Cadila
        11.5.1 Cadila Company Details
        11.5.2 Cadila Business Overview
        11.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.5.4 Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.5.5 Cadila Recent Developments
    11.6 Apotex
        11.6.1 Apotex Company Details
        11.6.2 Apotex Business Overview
        11.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.6.4 Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.6.5 Apotex Recent Developments
    11.7 Daewoong Pharmaceutical
        11.7.1 Daewoong Pharmaceutical Company Details
        11.7.2 Daewoong Pharmaceutical Business Overview
        11.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.7.4 Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.7.5 Daewoong Pharmaceutical Recent Developments
    11.8 Livzon
        11.8.1 Livzon Company Details
        11.8.2 Livzon Business Overview
        11.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.8.4 Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.8.5 Livzon Recent Developments
    11.9 Luoxin
        11.9.1 Luoxin Company Details
        11.9.2 Luoxin Business Overview
        11.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.9.4 Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.9.5 Luoxin Recent Developments
    11.10 Med shine
        11.10.1 Med shine Company Details
        11.10.2 Med shine Business Overview
        11.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.10.4 Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.10.5 Med shine Recent Developments
    11.11 Bayer (Campho Phenique)
        11.11.1 Bayer (Campho Phenique) Company Details
        11.11.2 Bayer (Campho Phenique) Business Overview
        11.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.11.4 Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.11.5 Bayer (Campho Phenique) Recent Developments
    11.12 Blistex
        11.12.1 Blistex Company Details
        11.12.2 Blistex Business Overview
        11.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.12.4 Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.12.5 Blistex Recent Developments
    11.13 Kelun
        11.13.1 Kelun Company Details
        11.13.2 Kelun Business Overview
        11.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.13.4 Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.13.5 Kelun Recent Developments
    11.14 Hikma
        11.14.1 Hikma Company Details
        11.14.2 Hikma Business Overview
        11.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.14.4 Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.14.5 Hikma Recent Developments
    11.15 Haiwang
        11.15.1 Haiwang Company Details
        11.15.2 Haiwang Business Overview
        11.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.15.4 Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.15.5 Haiwang Recent Developments
    11.16 Carmex
        11.16.1 Carmex Company Details
        11.16.2 Carmex Business Overview
        11.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.16.4 Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.16.5 Carmex Recent Developments
    11.17 Cipher
        11.17.1 Cipher Company Details
        11.17.2 Cipher Business Overview
        11.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Introduction
        11.17.4 Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
        11.17.5 Cipher Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Aciclovir
    Table 3. Key Players of Valacyclovir
    Table 4. Key Players of Famciclovir
    Table 5. Key Players of Docosanol
    Table 6. Key Players of Other
    Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2017-2022)
    Table 11. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2023-2028)
    Table 13. Drugs for Herpes Labialis (Oral Herpes) Market Trends
    Table 14. Drugs for Herpes Labialis (Oral Herpes) Market Drivers
    Table 15. Drugs for Herpes Labialis (Oral Herpes) Market Challenges
    Table 16. Drugs for Herpes Labialis (Oral Herpes) Market Restraints
    Table 17. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Players (2017-2022)
    Table 19. Global Top Drugs for Herpes Labialis (Oral Herpes) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2021)
    Table 20. Ranking of Global Top Drugs for Herpes Labialis (Oral Herpes) Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Drugs for Herpes Labialis (Oral Herpes) Product Solution and Service
    Table 24. Date of Enter into Drugs for Herpes Labialis (Oral Herpes) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2017-2022)
    Table 28. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2023-2028)
    Table 30. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2017-2022)
    Table 32. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2023-2028)
    Table 34. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2023-2028) & (US$ Million)
    Table 64. GSK Company Details
    Table 65. GSK Business Overview
    Table 66. GSK Drugs for Herpes Labialis (Oral Herpes) Product
    Table 67. GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 68. GSK Recent Developments
    Table 69. Novartis Company Details
    Table 70. Novartis Business Overview
    Table 71. Novartis Drugs for Herpes Labialis (Oral Herpes) Product
    Table 72. Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 73. Novartis Recent Developments
    Table 74. Teva Company Details
    Table 75. Teva Business Overview
    Table 76. Teva Drugs for Herpes Labialis (Oral Herpes) Product
    Table 77. Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 78. Teva Recent Developments
    Table 79. Mylan Company Details
    Table 80. Mylan Business Overview
    Table 81. Mylan Drugs for Herpes Labialis (Oral Herpes) Product
    Table 82. Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 83. Mylan Recent Developments
    Table 84. Cadila Company Details
    Table 85. Cadila Business Overview
    Table 86. Cadila Drugs for Herpes Labialis (Oral Herpes) Product
    Table 87. Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 88. Cadila Recent Developments
    Table 89. Apotex Company Details
    Table 90. Apotex Business Overview
    Table 91. Apotex Drugs for Herpes Labialis (Oral Herpes) Product
    Table 92. Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 93. Apotex Recent Developments
    Table 94. Daewoong Pharmaceutical Company Details
    Table 95. Daewoong Pharmaceutical Business Overview
    Table 96. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product
    Table 97. Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 98. Daewoong Pharmaceutical Recent Developments
    Table 99. Livzon Company Details
    Table 100. Livzon Business Overview
    Table 101. Livzon Drugs for Herpes Labialis (Oral Herpes) Product
    Table 102. Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 103. Livzon Recent Developments
    Table 104. Luoxin Company Details
    Table 105. Luoxin Business Overview
    Table 106. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product
    Table 107. Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 108. Luoxin Recent Developments
    Table 109. Med shine Company Details
    Table 110. Med shine Business Overview
    Table 111. Med shine Drugs for Herpes Labialis (Oral Herpes) Product
    Table 112. Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 113. Med shine Recent Developments
    Table 114. Bayer (Campho Phenique) Company Details
    Table 115. Bayer (Campho Phenique) Business Overview
    Table 116. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product
    Table 117. Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 118. Bayer (Campho Phenique) Recent Developments
    Table 119. Blistex Company Details
    Table 120. Blistex Business Overview
    Table 121. Blistex Drugs for Herpes Labialis (Oral Herpes) Product
    Table 122. Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 123. Blistex Recent Developments
    Table 124. Kelun Company Details
    Table 125. Kelun Business Overview
    Table 126. Kelun Drugs for Herpes Labialis (Oral Herpes) Product
    Table 127. Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 128. Kelun Recent Developments
    Table 129. Hikma Company Details
    Table 130. Hikma Business Overview
    Table 131. Hikma Drugs for Herpes Labialis (Oral Herpes) Product
    Table 132. Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 133. Hikma Recent Developments
    Table 134. Haiwang Company Details
    Table 135. Haiwang Business Overview
    Table 136. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product
    Table 137. Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 138. Haiwang Recent Developments
    Table 139. Carmex Company Details
    Table 140. Carmex Business Overview
    Table 141. Carmex Drugs for Herpes Labialis (Oral Herpes) Product
    Table 142. Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 143. Carmex Recent Developments
    Table 144. Cipher Company Details
    Table 145. Cipher Business Overview
    Table 146. Cipher Drugs for Herpes Labialis (Oral Herpes) Product
    Table 147. Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022) & (US$ Million)
    Table 148. Cipher Recent Developments
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Type: 2021 VS 2028
    Figure 2. Aciclovir Features
    Figure 3. Valacyclovir Features
    Figure 4. Famciclovir Features
    Figure 5. Docosanol Features
    Figure 6. Other Features
    Figure 7. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application: 2021 VS 2028
    Figure 8. External Use Case Studies
    Figure 9. Oral Case Studies
    Figure 10. Injection Case Studies
    Figure 11. Drugs for Herpes Labialis (Oral Herpes) Report Years Considered
    Figure 12. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Drugs for Herpes Labialis (Oral Herpes) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region: 2021 VS 2028
    Figure 15. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players in 2021
    Figure 16. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2021
    Figure 18. North America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Type (2017-2028)
    Figure 20. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Application (2017-2028)
    Figure 21. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Country (2017-2028)
    Figure 22. United States Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Country (2017-2028)
    Figure 28. Germany Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Region (2017-2028)
    Figure 38. China Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Country (2017-2028)
    Figure 48. Mexico Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Country (2017-2028)
    Figure 54. Turkey Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. GSK Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 58. Novartis Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 59. Teva Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 60. Mylan Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 61. Cadila Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 62. Apotex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 63. Daewoong Pharmaceutical Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 64. Livzon Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 65. Luoxin Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 66. Med shine Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 67. Bayer (Campho Phenique) Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 68. Blistex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 69. Kelun Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 70. Hikma Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 71. Haiwang Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 72. Carmex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 73. Cipher Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun
Hikma
Haiwang
Carmex
Cipher
Frequently Asked Questions
Drugs for Herpes Labialis (Oral Herpes) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drugs for Herpes Labialis (Oral Herpes) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drugs for Herpes Labialis (Oral Herpes) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gypsum-Fiber Board

Gypsum-Fiber Board market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Low Dielectric Resin

Low Dielectric Resin market is segmented by Type and by Application. Players, stakeholders, and o ... Read More